The Fed is pumping $80 billion a month into the markets. Strategies The Fed, not fundamentals, is driving the stock rally
Here's why we took a position in the iShares NASDAQ Biotechnology Index. Strategies Why biotech trumps big pharma in our portfolio
These misunderstandings aren't helping anyone. Outlook Four myths on the corporate tax dodging debate